Congress Wealth Management LLC DE Has $545,000 Stock Holdings in Premier, Inc. (NASDAQ:PINC)

Congress Wealth Management LLC DE lowered its position in shares of Premier, Inc. (NASDAQ:PINC) by 49.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 25,712 shares of the company’s stock after selling 25,488 shares during the quarter. Congress Wealth Management LLC DE’s holdings in Premier were worth $545,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. KLP Kapitalforvaltning AS acquired a new position in shares of Premier in the 4th quarter valued at $996,000. American Century Companies Inc. grew its stake in Premier by 4.2% in the fourth quarter. American Century Companies Inc. now owns 2,598,731 shares of the company’s stock valued at $55,093,000 after acquiring an additional 104,452 shares during the period. Advisors Asset Management Inc. increased its holdings in shares of Premier by 554.7% in the fourth quarter. Advisors Asset Management Inc. now owns 98,945 shares of the company’s stock worth $2,098,000 after acquiring an additional 83,831 shares in the last quarter. Kennondale Capital Management LLC acquired a new stake in shares of Premier during the fourth quarter worth about $675,000. Finally, Corient Private Wealth LLC bought a new position in shares of Premier during the 4th quarter valued at about $227,000. Institutional investors own 74.41% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Piper Sandler lowered their target price on Premier from $21.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Robert W. Baird dropped their price objective on shares of Premier from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Finally, Canaccord Genuity Group reduced their target price on shares of Premier from $21.00 to $19.00 and set a “hold” rating for the company in a research note on Wednesday, February 5th. Eight equities research analysts have rated the stock with a hold rating, According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $20.17.

Insiders Place Their Bets

In related news, Director Helen M. Boudreau sold 2,500 shares of Premier stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $21.42, for a total value of $53,550.00. Following the sale, the director now owns 20,668 shares of the company’s stock, valued at approximately $442,708.56. The trade was a 10.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.96% of the company’s stock.

Premier Stock Down 0.3 %

NASDAQ PINC opened at $19.14 on Friday. The firm’s 50 day moving average is $19.33 and its 200-day moving average is $20.47. The company has a market capitalization of $1.75 billion, a PE ratio of -191.38 and a beta of 0.39. Premier, Inc. has a 12-month low of $17.23 and a 12-month high of $23.56.

Premier Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Saturday, March 15th. Shareholders of record on Saturday, March 1st were paid a $0.21 dividend. The ex-dividend date was Friday, February 28th. This represents a $0.84 annualized dividend and a yield of 4.39%. Premier’s payout ratio is currently -840.00%.

Premier Profile

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.